Orange Pharma Private Limited

Orange Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U24239DL2004PTC124440 Incorporated 04 February 2004 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Revenue · FY 2025
₹7,100
▲ 16% YoY
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data

About Orange Pharma Private Limited

Data last updated:

Orange Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2004PTC124440.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunaina Jain and Kuldeep Jain.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N – 37 Sector 5 Dsidc Industrial Area Bawana, Delhi, India – 110039.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orangepharma.com.

Company details

CIN U24239DL2004PTC124440
Registration Number 124440
Incorporation Date 04 February 2004
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Orange Pharma Private Limited's registered office is in Delhi, Delhi. Its website is orangepharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    N – 37 Sector 5 Dsidc Industrial Area Bawana, Delhi, India – 110039
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Orange Pharma Private Limited, buy the company report.

Comprehensive company report
Orange Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Orange Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Orange Pharma Private Limited, buy the company report.

Financials of Orange Pharma Private Limited

FY 2025 filings available

Orange Pharma Private Limited reported revenue of ₹7,100 (up 16% YoY) for FY 2025.

Revenue · FY 2025
₹7,100 ▲ 16%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 7%
5 years · compounded
▼ 24%

Revenue rose 16% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 24%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Orange Pharma Private Limited, buy the company report.

Board of directors of Orange Pharma Private Limited

Orange Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sunaina JainDirector25 Aug 200917 Years 2 MonthsCurrent
Kuldeep JainDirector04 Feb 200422 Years 9 MonthsCurrent

Auditor

Orange Pharma Private Limited is audited by MANISH S GOEL & ASSOCIATES for the financial year 2016.

Auditor firmFinancial yearFirm registration number
MANISH S GOEL & ASSOCIATESFY 2016019894N

Shareholding

The shareholding of Orange Pharma Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Orange Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Orange Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Orange Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Orange Pharma Private Limited has 4 board changes on record since 2004: 2 appointments and 2 cessations. The latest: Sunaina Jain ceased to be Additional Director on 30 Sep 2009.

AGM
Orange Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Orange Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Sunaina Jain ceased to be Additional Director.
Ceased
Rajeev Jain ceased to be Director.
Appointed
Sunaina Jain was appointed as Director.
Appointed
Kuldeep Jain was appointed as Director.
Incorporation
04 Feb 2004
Orange Pharma Private Limited was registered on 04 Feb 2004 with Roc Delhi I & aged 22 years 9 months as per MCA records.

Frequently asked questions

Orange Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2004 (22+ years old) and is registered under CIN U24239DL2004PTC124440.

Orange Pharma has 2 current directors:

The latest financial statements of Orange Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Orange Pharma is U24239DL2004PTC124440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Orange Pharma was incorporated on 04 February 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.

Sunaina Jain ceased to be Additional Director on 30 Sep 2009. Rajeev Jain ceased to be Director on 28 Aug 2009. Sunaina Jain was appointed as Director on 25 Aug 2009. Orange Pharma has 4 board changes on record in total.

Orange Pharma can be reached through the website orangepharma.com. Its registered office is in Delhi, India.

The registered office of Orange Pharma is at N – 37 Sector 5 Dsidc Industrial Area Bawana, Delhi, India – 110039.

Orange Pharma operates in the pharma industry, in the drug formulation and development segment.

The compliance status of Orange Pharma is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.